<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140222016680N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-12</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Trunk Exercises on Balance and Activities of Daily Living in Individuals with Stroke</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Comprehensive Trunk Control Exercises  in comparison to Balance Exercises on Balance and Activities of Daily Living in Individuals with Stroke: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/94719</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: All stroke patients who are eligible for inclusion in the study will be assigned to two groups: control and comprehensive trunk control exercises using a block randomization method with variable block sizes of 4 or 6 people and an allocation ratio of 1:1, Blinding description: Due to the nature of the intervention, blinding of participants and intervention providers will not be possible. However, to reduce bias, the assessment of study outcomes will be conducted by assessors who are unaware of the group allocation of participants. Also, the statistical analyst will be unaware of the actual group allocation until the statistical analyses are finalized, and the groups will be identified by anonymous codes (such as A and B).</study_design>
      <phase>N/A</phase>
      <hc_freetext>stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, Comprehensive Trunk Control  exercises, will be given in a period of 6 weeks, three sessions per week. During eighteen sessions, 12 exercises are given with focus on improving balance in supine, sitting and standing positions. Each treatment session, depending on the patient needs to rest, lasts between 75 to 90 minutes. Required equipment are mats, swiss ball, chair, wall bar, inclined wedge and tilt board. Intervention 2: Control group:  In this group, Comprehensive Trunk Control  exercises, will be given in a period of 6 weeks, three sessions per week. During eighteen sessions, 12 exercises are given with focus on improving balance in supine, sitting and standing positions. Each treatment session, depending on the patient needs to rest, lasts between 75 to 90 minutes. Required equipment are mats, wall bar.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shohreh Noorizadeh Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Nezam Street, Shahnazari Street, Mirdamad Avenue, Tehran, Iran,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459-13487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>noorizadeh@razi.tums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shohreh Noorizadeh Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Nezam Street, Shahnazari Street, Mirdamad Avenue, Tehran, Iran,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459-13487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>noorizadeh@razi.tums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having age range between 60 and 80 years
Diagnosis of hemorrhagic or ischemic stroke based on CT scan or MRI imaging with physician confirmation
Stroke occurrence within 3 months to 10 years
Having a Montreal Cognitive Assessment score &gt;18
Having a trunk control test score &gt;48
Be able to stand for at least one minute or be able to walk independently for at least 10 meters with or without assistance.
Ability to sit without support for at least 30 seconds
Disability severity ≥3 according to the modified Rankin Scale
Being in phase three or higher of recovery according to the Brunnstrom stages
Ability to single leg stance on the affected side with or without assistance for at least 3 seconds</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having other neurological diseases (such as Parkinson, muscular dystrophy and neuropathy) and severe orthopedic diseases (such as amputations and surgeries related to lumbar discs and lumbar fixation) that affect motor function and balance
Patients whose stroke occurs solely and exclusively in the cerebellum and brainstem
Having unstable cardiovascular and respiratory vital functions
Having pusher syndrome
Having a visual field defect when performing a confrontation test
Having Star Cancellation Test score &lt;44, indicating unilateral spatial neglect
Occurrence of recurrent stroke during the study period
Having contractures of the elbow, wrist, and fingers in the less affected upper limb</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G81.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spastic hemiplegia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, Comprehensive Trunk Control  exercises, will be given in a period of 6 weeks, three sessions per week. During eighteen sessions, 12 exercises are given with focus on improving balance in supine, sitting and standing positions. Each treatment session, depending on the patient needs to rest, lasts between 75 to 90 minutes. Required equipment are mats, swiss ball, chair, wall bar, inclined wedge and tilt board.</i_keyword>
      <i_keyword>Control group:  In this group, Comprehensive Trunk Control  exercises, will be given in a period of 6 weeks, three sessions per week. During eighteen sessions, 12 exercises are given with focus on improving balance in supine, sitting and standing positions. Each treatment session, depending on the patient needs to rest, lasts between 75 to 90 minutes. Required equipment are mats, wall bar.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The Balance score in Berg Balance Scale. Timepoint: before first treatment session, after 15th session (last session) and 6 months after the last session. Method of measurement: Berg Balance Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Timed Up and Go Test. Timepoint: before first treatment session,  after 18th session (last session) and 6 months after the last session. Method of measurement: Timed Up and Go.</sec_outcome>
      <sec_outcome>Postural stability. Timepoint: before first treatment session,  after 18th session (last session) and 6 months after the last session. Method of measurement: balance Biodex system.</sec_outcome>
      <sec_outcome>Activities Daily Living. Timepoint: before first treatment session, after 18th session (last session) and 6 months after the last session. Method of measurement: Functional Independence Measure.</sec_outcome>
      <sec_outcome>Trunk Control Test. Timepoint: before first treatment session,  after 18th session (last session) and 6 months after the last session. Method of measurement: Trunk Control Test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-10-12</approval_date>
        <contact_name>Ethics committee of School of Rehabilitation Sciences-Iran University of Medical Sciences</contact_name>
        <contact_address>School of Rehabilitation Sciences, Madadkaran Street, Shahnazari Street, Madar Square, Mirdamad, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
